SCHEMBL18756129

SCHEMBL18756129

CC(C)CN1CCC(CN(C)C)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 4/20 0.38
HRH3 Q9Y5N1 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.33
CYP2D6 P10635 2/20 0.33
KDM4E B2RXH2 3/20 0.31
ALDH1A1 P00352 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
ROCK2 O75116 1/20 0.31
ROCK1 Q13464 1/20 0.31
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
ADRA1D P25100 1/20 0.31
ADRA1A P35348 1/20 0.31
ADRA1B P35368 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31
GRIN3A Q8TCU5 1/20 0.31
ABL1 P00519 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22837789 0.85 PIK3CD (0.36) PIK3CDHRH3SMN1; SMN2CYP2D6KDM4E
SCHEMBL23945766 0.83 PIK3CD (0.35) PIK3CDHRH3SMN1; SMN2CYP2D6
SCHEMBL22848927 0.83 PIK3CD (0.35) PIK3CDHRH3SMN1; SMN2CYP2D6ROCK2
SCHEMBL24171714 0.81 PIK3CD (0.36) PIK3CDHRH3SMN1; SMN2ALDH1A1ABL1
SCHEMBL23807306 0.80 PIK3CD (0.33) PIK3CDHRH3
SCHEMBL23696157 0.80 PIK3CD (0.37) PIK3CDHRH3
SCHEMBL21105877 0.79 PIK3CD (0.33) PIK3CDHRH3
SCHEMBL23842233 0.79 PIK3CD (0.46) PIK3CDHRH3SMN1; SMN2CYP2D6KDM4E
SCHEMBL21107430 0.79 PIK3CD (0.43) PIK3CDHRH3SMN1; SMN2CYP2D6KDM4E
SCHEMBL25691521 0.79 PIK3CD (0.43) PIK3CDHRH3SMN1; SMN2CYP2D6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023077077-A1 RNA DEGRADERS AND USES THEREOF ARRAKIS THERAPEUTICS, INC. (US) 2023-05-04 WO disclosed
WO-2022125790-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-06-16 WO disclosed
WO-2022125804-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-06-16 WO disclosed
WO-2022125800-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-06-16 WO disclosed
WO-2021011871-A1 MERTK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-01-21 WO disclosed
WO-2021011868-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-01-21 WO disclosed
WO-2020264490-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed
WO-2020251969-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-12-17 WO disclosed
WO-2020251971-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-12-17 WO disclosed
EP-3156410-A1 POLYENE MACROLIDE DERIVATIVE SHIONOGI & CO., LTD. (JP) 2017-04-19 EP disclosed